| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Seres Therapeutics, Inc. | Chief Scientific Officer and EVP | Common Stock | 77.8K | $42.1K | $0.54 | Nov 18, 2024 | Direct |
| Seres Therapeutics, Inc. | Chief Scientific Officer and EVP | Restricted Stock Units | 25.3K | $17.5K | $0.69 | Nov 15, 2024 | Direct |
| Seres Therapeutics, Inc. | Chief Scientific Officer and EVP | Stock Option (Right to Buy) | 288K | Feb 14, 2024 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| MCRB | Seres Therapeutics, Inc. | Nov 15, 2024 | 3 | -$501 | 4 | Nov 19, 2024 | Chief Scientific Officer and EVP |
| MCRB | Seres Therapeutics, Inc. | Oct 27, 2024 | 3 | -$2.75K | 4 | Oct 29, 2024 | Chief Scientific Officer and EVP |
| MCRB | Seres Therapeutics, Inc. | Aug 15, 2024 | 3 | -$775 | 4 | Aug 19, 2024 | Chief Scientific Officer and EVP |
| MCRB | Seres Therapeutics, Inc. | May 15, 2024 | 3 | -$838 | 4 | May 17, 2024 | Chief Scientific Officer and EVP |
| MCRB | Seres Therapeutics, Inc. | Feb 14, 2024 | 6 | -$4.5K | 4 | Feb 16, 2024 | Chief Scientific Officer and EVP |
| MCRB | Seres Therapeutics, Inc. | Oct 27, 2023 | 4 | -$5.25K | 4 | Oct 31, 2023 | Chief Scientific Officer and EVP |
| MCRB | Seres Therapeutics, Inc. | Apr 27, 2023 | 1 | $0 | 4 | May 1, 2023 | Chief Scientific Officer and EVP |
| MCRB | Seres Therapeutics, Inc. | Feb 3, 2023 | 2 | $0 | 4 | Feb 7, 2023 | Chief Scientific Officer and EVP |
| MCRB | Seres Therapeutics, Inc. | Sep 8, 2022 | 1 | $0 | 4 | Sep 9, 2022 | Chief Scientific Officer and EVP |
| MCRB | Seres Therapeutics, Inc. | Jul 5, 2022 | 1 | $150K | 4 | Jul 6, 2022 | Chief Scientific Officer and EVP |
| MCRB | Seres Therapeutics, Inc. | Feb 4, 2022 | 1 | $0 | 4 | Feb 8, 2022 | Chief Scientific Officer and EVP |